Carlsmed Income Statement (2024-2026) | CARL

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 6.08M6.59M9.41M12.08M13.07M15.16M16.12M
Cost of Revenue (Quarter) 4.87M1.95M1.07M7.87M9.61M-19.55M7.88M
Gross Profit (Quarter) 4.56M4.80M7.02M8.87M9.93M11.61M12.43M
Operating items
Research & Development (Quarter) 1.92M4.04M8.96M4.16M4.45M2.88M5.18M
Selling, General & Administrative (Quarter) 2.01M1.92M2.33M3.34M4.91M4.85M6.23M
Other Operating Expenses (Quarter) 6.95M6.62M0.43M7.87M9.61M13.20M10.30M
Operating Expenses (Quarter) 10.88M12.57M11.72M15.37M18.96M20.93M21.70M
Operating Income (Quarter) -6.32M-7.78M-4.70M-6.50M-9.04M-9.32M-9.28M
EBIT (Quarter) -6.32M-7.78M-4.70M-6.50M-9.04M-9.32M-9.28M
Non-operating items
Interest & Investment Income (Quarter) 0.43M0.39M0.41M0.34M0.95M1.03M0.89M
Other Non Operating Income (Quarter) 0.04M-0.04M-0.02M-0.26M0.51M0.70M0.58M
Non Operating Income (Quarter) 0.04M-0.04M13.20M-0.26M0.51M0.70M0.58M
Net income details
EBT (Quarter) -6.22M-7.79M-4.67M-6.53M-8.46M-8.62M-8.70M
Profit After Tax (Quarter) -6.28M-7.81M-4.72M-6.77M-8.53M-8.61M-8.70M
Income from Continuing Operations (Quarter) -6.22M-7.79M-4.67M-6.53M-8.46M-8.62M-8.70M
Consolidated Net Income (Quarter) -6.22M-7.79M-4.67M-6.53M-8.46M-8.62M-8.70M
Income towards Parent Company (Quarter) -6.22M-7.79M-4.67M-6.53M-8.46M-8.62M-8.70M
Preferred Dividend Payments (Quarter) 0.59M0.58M
Net Income towards Common Stockholders (Quarter) -6.28M-8.40M-4.72M-6.77M-8.53M-8.61M-8.70M
Additional items
EPS (Basic) (Quarter) -1.55-2.06-1.14-1.47-0.400.03-0.32
EPS (Weighted Average and Diluted) (Quarter) -1.55-2.06-1.14-1.47-0.400.03-0.32
Shares Outstanding (Weighted Average) (Quarter) 4.05M4.05M4.07M4.45M10.05M14.22M26.84M
Shares Outstanding (Diluted Average) (Quarter) 4.05M4.05M4.07M4.45M10.05M14.22M26.84M
EBITDA (Quarter) -6.28M-7.81M-4.72M-6.77M-8.53M-8.61M-8.70M
Interest Expenses (Quarter) 0.33M0.40M0.38M0.36M0.38M0.33M0.31M